The Tat protein of human immunodeficiency virus-1 enhances hepatitis C virus replication through interferon gamma-inducible protein-10

被引:24
作者
Qu, Jing [1 ,2 ]
Zhang, Qi [1 ,2 ]
Li, Youxing [1 ,2 ]
Liu, Weiyong [1 ,2 ]
Chen, Lvxiao [1 ,2 ]
Zhu, Ying [1 ,2 ,3 ]
Wu, Jianguo [1 ,2 ,3 ,4 ,5 ]
机构
[1] Wuhan Univ, Zhongnan Hosp, Coll Life Sci, State Key Lab Virol, Wuhan 430072, Peoples R China
[2] Wuhan Univ, Zhongnan Hosp, Chinese French Liver Dis Res Inst, Wuhan 430072, Peoples R China
[3] Wuhan Inst Biotechnol, Wuhan 430075, Peoples R China
[4] Wuhan Univ, State Key Lab Virol, Wuhan 430072, Peoples R China
[5] Wuhan Univ, Coll Life Sci, Wuhan 430072, Peoples R China
基金
中国国家自然科学基金;
关键词
ACTIVE ANTIRETROVIRAL THERAPY; PERIPHERAL-BLOOD MONOCYTES; HIV-INFECTION; TYPE-1; TAT; FIBROSIS PROGRESSION; MESSENGER-RNA; LIVER-DISEASE; JC VIRUS; IP-10; CHEMOKINE;
D O I
10.1186/1471-2172-13-15
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Background: Co-infection with human immunodeficiency virus-1 (HIV-1) and hepatitis C virus (HCV) is associated with faster progression of liver disease and an increase in HCV persistence. However, the mechanism by which HIV-1 accelerates the progression of HCV liver disease remains unknown. Results: HIV-1/HCV co-infection is associated with increased expression of interferon gamma-induced protein-10 (IP-10) mRNA in peripheral blood mononuclear cells (PBMCs). HCV RNA levels were higher in PBMCs of patients with HIV-1/HCV co-infection than in patients with HCV mono-infection. HIV-1 Tat and IP-10 activated HCV replication in a time-dependent manner, and HIV-1 Tat induced IP-10 production. In addition, the effect of HIV-1 Tat on HCV replication was blocked by anti-IP-10 monoclonal antibody, demonstrating that the effect of HIV-1 Tat on HCV replication depends on IP-10. Taken together, these results suggest that HIV-1 Tat protein activates HCV replication by upregulating IP-10 production. Conclusions: HIV-1/HCV co-infection is associated with increased expression of IP-10 mRNA and replication of HCV RNA. Furthermore, both HIV-1 Tat and IP-10 activate HCV replication. HIV-1 Tat activates HCV replication by upregulating IP-10 production. These results expand our understanding of HIV-1 in HCV replication and the mechanism involved in the regulation of HCV replication mediated by HIV-1 during co-infection.
引用
收藏
页数:12
相关论文
共 51 条
[1]   CXC chemokines IP-10 and Mig expression and direct migration of pulmonary CD8+/CXCR3+T cells in the lungs of patients with HIV infection and T-cell alveolitis [J].
Agostini, C ;
Facco, M ;
Siviero, M ;
Carollo, D ;
Galvan, S ;
Cattelan, AM ;
Zambello, R ;
Trentin, L ;
Semenzato, G .
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2000, 162 (04) :1466-1473
[2]   Tat protein of human immunodeficiency virus type 1 induces interleukin-10 in human peripheral blood monocytes: Implication of protein kinase C-dependent pathway [J].
Badou, A ;
Bennasser, Y ;
Moreau, M ;
Leclerc, C ;
Benkirane, M ;
Bahraoui, E .
JOURNAL OF VIROLOGY, 2000, 74 (22) :10551-10562
[3]   HCV recovery from peripheral blood mononuclear cell culture supernatants derived from HCV-HIV co-infected haemophilic patients with undetectable HCV viraemia [J].
Baré, P ;
Massud, I ;
Belmonte, L ;
Corti, M ;
Villafañe, M ;
Bianco, RP ;
De Tezanos-Pinto, M ;
De Bracco, MME ;
Ruibal-Ares, B .
HAEMOPHILIA, 2003, 9 (05) :598-604
[4]   Evidence that both HIV and HIV-induced immunodeficiency enhance HCV replication among HCV seroconverters [J].
Beld, M ;
Penning, M ;
Lukashov, V ;
McMorrow, M ;
Roos, M ;
Pakker, N ;
van den Hoek, A ;
Goudsmit, J .
VIROLOGY, 1998, 244 (02) :504-512
[5]   Liver fibrosis progression in human immunodeficiency virus and hepatitis C virus coinfected patients [J].
Benhamou, Y ;
Bochet, M ;
Di Martino, V ;
Charlotte, F ;
Azria, F ;
Coutellier, A ;
Vidaud, M ;
Bricaire, F ;
Opolon, P ;
Katlama, C ;
Poynard, T .
HEPATOLOGY, 1999, 30 (04) :1054-1058
[6]   HIV-1 Tat protein induces interleukin-10 in human peripheral blood monocytes:: involvement of protein kinase C-βII and -δ [J].
Bennasser, Y ;
Bahraoui, E .
FASEB JOURNAL, 2002, 16 (06) :546-554
[7]   Survival in patients with HIV infection and viral hepatitis B or C: a cohort study [J].
Bonacini, M ;
Louie, S ;
Bzowej, N ;
Wohl, AR .
AIDS, 2004, 18 (15) :2039-2045
[8]   Plasma chemokine levels correlate with the outcome of antiviral therapy in patients with hepatitis C [J].
Butera, D ;
Marukian, S ;
Iwamaye, AE ;
Hembrador, E ;
Chambers, TJ ;
Di Bisceglie, AM ;
Charles, ED ;
Talal, AH ;
Jacobson, IM ;
Rice, CM ;
Dustin, LB .
BLOOD, 2005, 106 (04) :1175-1182
[9]   The Tat protein of HIV-1 induces tumor necrosis factor-alpha production - Implications for HIV-1-associated neurological diseases [J].
Chen, PQ ;
Mayne, M ;
Power, C ;
Nath, A .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1997, 272 (36) :22385-22388
[10]   Cerebrospinal fluid interferon-γ-inducible protein 10 (IP-10, CXCL10) in HIV-1 infection [J].
Cinque, P ;
Bestetti, A ;
Marenzi, R ;
Sala, S ;
Gisslen, M ;
Hagberg, L ;
Price, RW .
JOURNAL OF NEUROIMMUNOLOGY, 2005, 168 (1-2) :154-163